Short supply of commonly used cancer drugs raises concerns among hospital pharmacists
Experts who track drug supply and care for cancer patients say they are watching with concern about shortages of several generic drugs that are widely used in treating cancer patients.
Three drugs used in various cancer treatments are currently on the shortage list kept by the American Society of Health-System Pharmacists (ASHP). Those include methotrexate, which treats cancer by slowing the growth of cancer cells; cisplatin, a backbone of chemotherapy for advanced cancers in the ovaries, bladder and other locations; and fluorouracil, another widely used chemotherapy drug.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,900+ biopharma pros reading Endpoints daily — and it's free.